DOI: 10.2337/db06-0384 © 2007 by the American Diabetes Association Antidiabetic Effects of cis-9, trans-11–Conjugated Linoleic Acid May Be Mediated via Anti-Inflammatory Effects in White Adipose Tissue
1 Nutrigenomics Research Group, Department of Clinical Medicine, Institute of Molecular Medicine, Trinity College Dublin, St. Jamess Hospital, Dublin, Ireland Address correspondence and reprint requests to Helen M. Roche, Nutrigenomics Research Group, Department of Clinical Medicine, Institute of Molecular Medicine, Trinity College Dublin, St. Jamess Hospital, Dublin 8, Ireland. E-mail: hmroche{at}tcd.ie
Abbreviations:
c9,t11-CLA, cis-9, trans-11–conjugated linoleic acid; t10,c12-CLA, trans-10, cis-12–conjugated linoleic acid; CLA, conjugated linoleic acid; HOMA-IR, homeostasis model assessment for insulin resistance; IRS, insulin receptor substrate; LXR, liver X receptor; NEFA, nonesterified fatty acid; NF, nuclear factor; QUICKI, quantitative insulin sensitivity check index; SREBP, sterol regulatory element binding protein; TNF, tumor necrosis factor; TZD, thiazolidinedione
Adipose tissue may be the source of insulin desensitizing proinflammatory molecules that predispose to insulin resistance. This study investigated whether dietary fatty acids could attenuate the proinflammatory insulin-resistant state in obese adipose tissue. The potential antidiabetic effect of cis-9, trans-11–conjugated linoleic acid (c9,t11-CLA) was determined, focusing on the molecular markers of insulin sensitivity and inflammation in adipose tissue of ob/ob C57BL-6 mice. Feeding a c9,t11-CLA–enriched diet reduced fasting glucose (P < 0.05), insulin (P < 0.05), and triacylglycerol concentrations (P < 0.01) and increased adipose tissue plasma membrane GLUT4 (P < 0.05) and insulin receptor (P < 0.05) expression compared with the control linoleic acid–enriched diet. Interestingly, after the c9,t11-CLA diet, adipose tissue macrophage infiltration was less, with marked downregulation of several inflammatory markers in adipose tissue, including reduced tumor necrosis factor-
|
|
|
||||||||||||||||||||||||||